Literature DB >> 12165058

High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis.

C P Chiang1, R P Hsieh, T H H Chen, Y F Chang, B Y Liu, J T Wang, A Sun, M Y P Kuo.   

Abstract

BACKGROUND: Previous study has shown a high incidence of autoantibodies including antinuclear (ANA), antismooth muscle (SMA), antigastric parietal cell (GPCA), antithyroid microsomal (TMA), and antireticulin antibodies in a small group of 26 patients with oral submucous fibrosis (OSF). The reasons why some of the OSF patients have high titers of autoantibodies in serum have not been completely explained and no further study on autoantibodies in OSF patients has been done in a large group of patients.
METHODS: In this study, we determined the serum levels of ANA, SMA, GPCA, and TMA in a large group of 109 male Taiwanese patients with OSF by an indirect immunofluorescence technique (for ANA, SMA, and GPCA), and by a semiquantitative microtiter particle agglutination test (for TMA). The presence of serum autoantibodies in OSF patients was further correlated with patients' oral habits and the severity of OSF measured by maximum mouth opening (MMO) and sites of involvement.
RESULTS: We found that the frequencies of presence of serum ANA (23.9%), SMA (23.9%), and GPCA (14.7%) in OSF patients were significantly higher than those (9.2, 7.3, and 5.5%, respectively) in healthy control subjects (P < 0.01, P < 0.005, and P < 0.05, respectively). Although the frequency of presence of TMA (5.5%) in OSF patients was also greater than that (2.8%) in healthy control subjects, the difference was not significant (P > 0.05). The presence of serum GPCA in OSF patients was significantly associated with daily areca quid (AQ) consumption (P < 0.05). The presence of serum ANA in OSF patients associated with daily AQ consumption was of borderline statistical significance (P = 0.066). However, no significant correlations were demonstrated between the presence of serum autoantibodies in OSF patients and other variables of oral habits, MMO, and sites of involvement.
CONCLUSION: In this study, all the 109 OSF patients had AQ chewing habit and 73.4% of the OSF patients swallowed the 'juice' of AQ during the chewing process. The presence of serum GPCA and ANA in OSF patients was associated with daily consumption of AQs. AQ chewing caused mucosal microtrauma, and ulcerations facilitated the diffusion of genotoxic and cytotoxic AQ ingredients into the oral and gastric tissues. Altered autoantigens released from AQ ingredients-damaged cells may induce autoantibody production. Higher frequencies of specific HLA-DR antigens in OSF patients may also help autoantibody production. Therefore, we conclude that the high incidence of autoantibodies in OSF patients may be due to AQ chewing habit, toxic AQ ingredients, and genetic susceptibility of the OSF patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165058     DOI: 10.1034/j.1600-0714.2002.00117.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  19 in total

1.  Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma.

Authors:  Bharath Rao K; N Malathi; Sangeetha Narashiman; Sharada T Rajan
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 2.  Management of oral submucous fibrosis: an overview.

Authors:  Punnya V Angadi; Sanjay Rao
Journal:  Oral Maxillofac Surg       Date:  2010-09

3.  Cys-X-Cys ligand 9 might be an immunological factor in the pathogenesis of oral submucous fibrosis and its concomitant oral lichenoid lesion.

Authors:  Ning Li; Qiong Hu; Canhua Jiang; Feng Guo; Krishna Munnee; Xinchun Jian; Yanjia Hu; Zhangui Tang
Journal:  Clin Oral Investig       Date:  2012-07-21       Impact factor: 3.573

Review 4.  Areca nut in pathogenesis of oral submucous fibrosis: revisited.

Authors:  Punnya V Angadi; Sanjay S Rao
Journal:  Oral Maxillofac Surg       Date:  2011-03

5.  Estimation of serum and salivary immunoglobulin G and immunoglobulin A in oral pre-cancer: A study in oral submucous fibrosis and oral lichen planus.

Authors:  V C Divya; S Sathasivasubramanian
Journal:  J Nat Sci Biol Med       Date:  2014-01

Review 6.  Areca nut and its role in oral submucous fibrosis.

Authors:  Rachana V Prabhu; Vishnudas Prabhu; Laxmikanth Chatra; Prashant Shenai; Nithin Suvarna; Savita Dandekeri
Journal:  J Clin Exp Dent       Date:  2014-12-01

7.  Comparative evaluation of serum and salivary immunoglobulin G and A levels with total serum protein in oral submucous fibrosis patients: A case control study.

Authors:  M Kandasamy; N Jaisanghar; Ravi David Austin; Kumar Chandan Srivastava; G Sai Anusuya; N Anisa
Journal:  J Pharm Bioallied Sci       Date:  2016-10

8.  PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix.

Authors:  Jie Wang; Jialing You; Lekai Wang; Huimin Wang; Tian Tian; Wenjin Wang; Lina Jia; Canhua Jiang
Journal:  Oncotarget       Date:  2017-08-24

Review 9.  Biochemical markers in oral submucous fibrosis: A review and update.

Authors:  V V Kamath; K Satelur; Y Komali
Journal:  Dent Res J (Isfahan)       Date:  2013-09

10.  Characterization of anti-nuclear antibodies in patients with oral submucous fibrosis and its clinicopathologic implications - An immunofluorescence study.

Authors:  Aprna Gupta; Surya Narayan Das; Bijoy Kumar Das; Lipsa Bhuyan
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.